You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 248 No. 12, September 24, 1982 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (19)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Drug Monitoring of Surgical Patients

David A. Danielson, MS; Jane B. Porter, MS; Barbara J. Dinan, RN; Patrick C. O'Connor, MB, MRCP, PhD; David H. Lawson, MD, FRCP; Gavin S. M. Kellaway, MD; Hershel Jick, MD

JAMA. 1982;248(12):1482-1485.


Abstract

Intensive drug monitoring of surgical patients was carried out on selected wards in five hospitals in the United States, Scotland, and New Zealand from 1977 through 1981. This report describes the methods and some findings from the monitoring of 5,232 such patients. Patients received, on the average, nine drugs on the ward, and adverse reactions were associated with 2.2% of these drug orders. Of the 1,150 drug-attributed adverse reactions, only 62 were considered "major" by the attending physician, and 35 (affecting 20 patients) were termed "life threatening." There were no drug-attributed deaths.

(JAMA 1982;248:1482-1485)



Author Affiliations

From the Boston Collaborative Drug Surveillance Program, Boston University Medical Center, Waltham, Mass.


Footnotes

Reprint requests to Boston Collaborative Drug Surveillance Program, 400-1 Totten Pond Rd, Waltham, MA 02154 (Dr Jick).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Drug-Induced Cutaneous Reactions: A Report From the Boston Collaborative Drug Surveillance Program on 15 438 Consecutive Inpatients, 1975 to 1982
Bigby et al.
JAMA 1986;256:3358-3363.
ABSTRACT  

Intensive Hospital Monitoring Study of Intravenous Cimetidine
Porter et al.
Arch Intern Med 1986;146:2237-2239.
ABSTRACT  

Adverse Tissue Reactions to Drugs: a Five-year Surveillance Study
Mikhael and Kacew
Hum Exp Toxicol 1985;4:583-590.
ABSTRACT  

Monitoring of Adverse Drug Reactions by means of Autopsy Tissue Examination
Mikhael and Kacew
Hum Exp Toxicol 1984;3:133-140.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1982 American Medical Association. All Rights Reserved.